JP2004526737A5 - - Google Patents

Download PDF

Info

Publication number
JP2004526737A5
JP2004526737A5 JP2002576627A JP2002576627A JP2004526737A5 JP 2004526737 A5 JP2004526737 A5 JP 2004526737A5 JP 2002576627 A JP2002576627 A JP 2002576627A JP 2002576627 A JP2002576627 A JP 2002576627A JP 2004526737 A5 JP2004526737 A5 JP 2004526737A5
Authority
JP
Japan
Prior art keywords
group
compound
compound according
oligonucleotide
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2002576627A
Other languages
English (en)
Japanese (ja)
Other versions
JP2004526737A (ja
JP4854913B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2002/009138 external-priority patent/WO2002077184A2/en
Publication of JP2004526737A publication Critical patent/JP2004526737A/ja
Publication of JP2004526737A5 publication Critical patent/JP2004526737A5/ja
Application granted granted Critical
Publication of JP4854913B2 publication Critical patent/JP4854913B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP2002576627A 2001-03-23 2002-03-21 オリゴヌクレオチド結合体 Expired - Lifetime JP4854913B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US27832201P 2001-03-23 2001-03-23
US60/278,322 2001-03-23
PCT/US2002/009138 WO2002077184A2 (en) 2001-03-23 2002-03-21 Oligonucleotide conjugates

Publications (3)

Publication Number Publication Date
JP2004526737A JP2004526737A (ja) 2004-09-02
JP2004526737A5 true JP2004526737A5 (enExample) 2005-12-22
JP4854913B2 JP4854913B2 (ja) 2012-01-18

Family

ID=23064542

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002576627A Expired - Lifetime JP4854913B2 (ja) 2001-03-23 2002-03-21 オリゴヌクレオチド結合体

Country Status (5)

Country Link
EP (1) EP1379689B1 (enExample)
JP (1) JP4854913B2 (enExample)
AU (1) AU2002245717A1 (enExample)
CA (1) CA2440322C (enExample)
WO (1) WO2002077184A2 (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7563618B2 (en) 2001-03-23 2009-07-21 Geron Corporation Oligonucleotide conjugates
DK3342425T3 (da) 2003-09-09 2020-03-16 Geron Corp Modificerede oligonukleotider til inhibering af telomerase
WO2005116207A1 (ja) * 2004-05-28 2005-12-08 Sankyo Company, Limited テロメラーゼ阻害enaオリゴヌクレオチド
RS61840B1 (sr) 2004-07-02 2021-06-30 Geron Corp Sinteza zaštićenih 3'-amino 5'-fosforamidit nukleozidnih monomera
US9228189B2 (en) 2012-10-26 2016-01-05 Geron Corporation C-myc antisense oligonucleotides and methods for using the same to treat cell-proliferative disorders
US9200327B2 (en) 2012-11-30 2015-12-01 Geron Corporation Diagnostic markers for treating cell proliferative disorders with telomerase inhibitors
US9375485B2 (en) 2012-12-07 2016-06-28 Geron Corporation Use of telomerase inhibitors for the treatment of myeloproliferative disorders and myeloproliferative neoplasms
EP3052512A4 (en) 2013-09-30 2017-02-22 Geron Corporation Phosphorodiamidate backbone linkage for oligonucleotides
JOP20200257A1 (ar) * 2014-05-01 2017-06-16 Geron Corp تركيبات أوليجو نوكليوتيد وطرق لتحضيرها
JP2018513127A (ja) 2015-04-23 2018-05-24 ジェロン・コーポレーションGeron Corporation 多価カチオン塩組成物を用いたポリヌクレオチド調製方法
EP3658156B1 (en) 2017-07-28 2026-03-25 Geron Corporation Telomerase inhibitor for use in treating a myelodysplastic syndrome
CN113631719A (zh) 2018-11-29 2021-11-09 美国杰龙生物医药公司 治疗骨髓增生异常综合征的方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4965349A (en) * 1987-12-24 1990-10-23 Applied Biosystems, Inc. Method of synthesizing oligonucleotides labeled with ammonia-labile groups on solid phase supports
US5352803A (en) * 1992-03-30 1994-10-04 Abbott Laboratories 5(6)-methyl substituted fluorescein derivatives
US5863726A (en) * 1993-11-12 1999-01-26 Geron Corporation Telomerase activity assays
JP3189000B2 (ja) * 1994-12-01 2001-07-16 東ソー株式会社 特定核酸配列の検出方法
WO2000050279A1 (en) * 1999-02-23 2000-08-31 Recreational Technologies International Llc Vehicle leveling assembly
HK1049339B (en) * 1999-09-10 2008-06-27 Geron Corporation Oligonucleotide n3'-p5' thiophosphoramidates: their synthesis and use

Similar Documents

Publication Publication Date Title
JP2007504830A5 (enExample)
JP2011092201A5 (enExample)
CN100400045C (zh) 基于核酸的化合物及其使用方法
JP7348922B2 (ja) B型肝炎感染の治療用のPAPD5及びPAPD7 mRNAを低減させるための核酸分子
JP2009524696A5 (enExample)
JP2018521970A (ja) ペプチドオリゴヌクレオチドコンジュゲート
JP2016502858A5 (enExample)
JP2016513976A5 (enExample)
JP2006518197A5 (enExample)
TWI740866B (zh) 肽寡核苷酸結合物
US20020160969A1 (en) Nucleosides and oligonucleotides containing boron clusters
BRPI0717510A2 (pt) Análogos de oligonucleotídeo cpg contendo análogos t hidrofóbicos com atividade imunoestimulatória intensificada
JP2023153970A5 (enExample)
WO2005113571A3 (en) Methods for the delivery of oligomeric compounds
DE60038495D1 (de) Oligonukleotid n3'-p5' thiophosphoramidate: ihre synthese und verwendung
JP2021072862A5 (enExample)
JP2003523739A5 (enExample)
JP2005525991A5 (enExample)
JP2019525918A5 (enExample)
JP2021506246A5 (enExample)
JP2006502243A5 (enExample)
JP2013537404A5 (enExample)
JP2004501211A5 (enExample)
JP2021524277A (ja) Rtel1発現の調節用のオリゴヌクレオチド
JP7356416B2 (ja) 二環式ペプチドオリゴヌクレオチドコンジュゲート